Axiomancer

Invest

Private-preview autonomous US options and equities paper-trading research, with deterministic selection and risk controls in the decision path.

Invest paper-trading portfolio overview showing net liquidation, daily profit and loss, open options positions, and risk-limit utilization
  • Private-preview research remains limited to US options and equities paper trading.
  • Candidate generation is separated from deterministic selection and validation.
  • Fail-closed controls can block a paper order before it is submitted.
Product preview
The portfolio view keeps open paper positions and risk-limit utilization visible together.

Invest is in private preview and operates in paper trading only. It is not investment advice. There is no public self-serve signup or product API today.

The decision path

  1. Gather evidence

    Market and portfolio context inform the research set.

  2. Generate candidates

    A high-recall system expands the research frontier.

  3. Select and validate

    Deterministic systems decide which candidates can proceed.

  4. Gate paper orders

    A fail-closed risk gate either permits a paper order or produces no order.

  5. Monitor lifecycle

    Controls remain available after an approved entry.

Market and portfolio evidence inform a high-recall candidate generator; deterministic systems select, validate, and gate any paper order.

What Invest is proving

The north star is clear: the LLM expands the research frontier, while a deterministic selector decides and breaks loops. That selector is still being proven load-bearing; these docs describe the intended operating model, not a completed claim.

An approved entry does not remove the need for ongoing control. Exit paths remain available even when new entries are blocked.

Invest changes land weekly during the preview. Follow them in the changelog.

Was this page helpful?

On this page